Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Greenwich LifeSciences (GLSI) Other Non-Current Liabilities (2024 - 2025)

Greenwich LifeSciences filings provide 2 years of Other Non-Current Liabilities readings, the most recent being $306281.0 for Q2 2025.

  • Quarterly Other Non-Current Liabilities changed N/A to $306281.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $306281.0 through Jun 2025, changed N/A year-over-year, with the annual reading at $306281.0 for FY2024, N/A changed from the prior year.
  • Other Non-Current Liabilities hit $306281.0 in Q2 2025 for Greenwich LifeSciences, roughly flat from $306281.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $306281.0 in Q4 2024 and bottomed at $306281.0 in Q4 2024.